How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/lymph-node-positive-colorectal-carcinoma.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-11 · How we verify

Lymph Node Positive Colorectal Carcinoma — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lymph Node Positive Colorectal Carcinoma (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Lymph Node Positive Colorectal Carcinoma, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Eloxatin	Oxaliplatin	Yakult Honsha	Platinum-based chemotherapy agent	DNA	2002-01-01
Xeloda	capecitabine	Cheplapharm	Nucleoside Metabolic Inhibitor [EPC]	Thymidylate synthase	1998-01-01
Xeloda	Xeloda	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins		Thymidylate synthase

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Cheplapharm · 1 drug in Lymph Node Positive Colorectal Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · 1 drug in Lymph Node Positive Colorectal Carcinoma
Yakult Honsha · 1 drug in Lymph Node Positive Colorectal Carcinoma

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Lymph Node Positive Colorectal Carcinoma:

Cite this brief

Drug Landscape (2026). Lymph Node Positive Colorectal Carcinoma — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/lymph-node-positive-colorectal-carcinoma. Accessed 2026-06-11.

Lymph Node Positive Colorectal Carcinoma full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing